دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
دانلود کتاب Pharmacoepidemiology, Third Edition
دانلود کتاب فارماکوپیدمیولوژی، چاپ سوم
مشخصات کتاب
Pharmacoepidemiology, Third Edition
ویرایش: سری: ISBN (شابک) : 9780471899259, 9780470842553 ناشر: John Wiley & Sons, Ltd سال نشر: 2000 تعداد صفحات: 863 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 14 مگابایت
قیمت کتاب (تومان) : 44,000
در صورت تبدیل فایل کتاب Pharmacoepidemiology, Third Edition به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب فارماکوپیدمیولوژی، چاپ سوم نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
توضیحاتی در مورد کتاب فارماکوپیدمیولوژی، چاپ سوم
Server Error
توضیحاتی درمورد کتاب به خارجی
Content:
Chapter 1 What is Pharmacoepidemiology? (pages 1–15): Brian L.
Strom
Chapter 2 Study Designs Available for Pharmacoepidemiology
Studies (pages 17–29): Brian L. Strom
Chapter 3 Sample Size Considerations for Pharmacoepidemiology
Studies (pages 31–39): Brian L. Strom
Chapter 4 Basic Principles of Clinical Pharmacology Relevant to
Pharmacoepidemiology Studies (pages 41–62): Patricia
McGettigan, David A. Henry and Sean Hennessy
Chapter 5 When Should One Perform Pharmacoepidemiology Studies?
(pages 63–71): Brian L. Strom
Chapter 6 The Public Health, the University, and
Pharmacoepidemiology (pages 73–89): Paul D. Stolley and
Joan?Ramon Laporte
Chapter 7 A View From Industry (pages 91–108): Dale B. Glasser
and Gretchen S. Dieck
Chapter 8 A View From Regulatory Agencies (pages 109–124):
David J. Graham, Patrick C. Waller and Xavier Kurz
Chapter 9 A View From a US Courtroom (pages 125–148): James R.
Ruger and Sidney H. Willig
Chapter 10 Spontaneous Reporting in the United States (pages
149–174): Dianne L. Kennedy, Stephen A. Goldman and Ralph B.
Lillie
Chapter 11 Spontaneous Reporting Systems Outside the US (pages
175–192): Bengt?Erik Wiholm, Sten Olsson, Nicholas Moore and
Patrick Waller
Chapter 12 Intensive Hospital?based Cohort Studies (pages
193–207): Keith Beard and David H. Lawson
Chapter 13 Case–Control Surveillance (pages 209–230): Samuel
Shapiro
Chapter 14 Prescription?event Monitoring (pages 231–246):
Ronald D. Mann
Chapter 15 Group Health Cooperative of Puget Sound (pages
247–262): Kathleen W. Saunders, Robert L. Davis and Andy
Stergachis
Chapter 16 Kaiser Permanente Medical Care Program: Division of
Research, Northern California, and Center for Health Research,
Northwest Division (pages 263–283): Gary D. Friedman, Laurel A.
Habel, Myde Boles and Bentson H. McFarland
Chapter 17 Harvard Pilgrim Health Care/Harvard Vanguard Medical
Associates (pages 285–293): K. Arnold Chan and Richard
Platt
Chapter 18 UnitedHealth Group (pages 295–305): Deborah Shatin,
Carole Drinkard and Andy Stergachis
Chapter 19 Medicaid Databases (pages 307–324): Jeffrey L.
Carson, Wayne A. Ray and Brian L. Strom
Chapter 20 Health Databases in Saskatchewan (pages 325–345):
Winanne Downey, Patricia Beck, Mary McNutt, Mary Rose Stang,
William Osei and Jim Nichol
Chapter 21 Automated Pharmacy Record Linkage in The Netherlands
(pages 347–360): Hubert G. Leufkens and John Urquhart
Chapter 22 The Tayside Medicines Monitoring Unit (MEMO) (pages
361–374): Josie M.M. Evans and Thomas M. Macdonald
Chapter 23 The UK General Practice Research Database (pages
375–385): Luis Alberto Garcia Rodriguez, Susanne Perez?Gutthann
and Susan Jick
Chapter 24 Other Approaches to Pharmacoepidemiology Studies
(pages 387–399): Brian L. Strom
Chapter 25 How Should One Perform Pharmacoepidemiology Studies?
Choosing Among the Available Alternatives (pages 401–413):
Brian L. Strom
Chapter 26 Bioethical Issues in Pharmacoepidemiology Research
(pages 415–431): David Casarett, Jason Karlawish, Elizabeth
Andrews and Arthur Caplan
Chapter 27 National Medicinal Drug Policies: their Relationship
to Pharmacoepidemiology (pages 433–447): Suzanne Hill and David
A. Henry
Chapter 28 Premarketing Applications of Pharmacoepidemiology
(pages 449–462): Harry A. Guess
Chapter 29 Studies of Drug Utilization (pages 463–481): David
Lee and Ulf Bergman
Chapter 30 Evaluating and Improving Physician Prescribing
(pages 483–503): Stephen B. Soumerai, Sumit Majumdar and Helene
L. Lipton
Chapter 31 Drug Utilization Review (pages 505–523): Sean
Hennessy, Brian L. Strom, Helene L. Lipton and Stephen B.
Soumerai
Chapter 32 Determining Causation from Case Reports (pages
525–538): Judith K. Jones
Chapter 33 The Use of Randomized Controlled Trials for
Pharmacoepidemiology Studies (pages 539–552): Samuel M. Lesko
and Allen A. Mitchell
Chapter 34 The Use of Pharmacoepidemiology to Study Beneficial
Drug Effects (pages 553–572): Brian L. Strom and Kenneth L.
Melmon
Chapter 35 Pharmacoeconomics: Economic Evaluation of
Pharmaceuticals (pages 573–601): Kevin A. Schulman, Henry
Glick, Daniel Polsky and John M. Eisenberg
Chapter 36 Using Quality of Life Measurements in
Pharmacoepidemiology Research (pages 603–613): Gordon H. Guyatt
and Roman Jaeschke
Chapter 37 N?of?1 Randomized Clinical Trials in
Pharmacoepidemiology (pages 615–631): Gordon H. Guyatt, Roman
Jaeschke and Robin Roberts
Chapter 38 The Use of Meta?analysis in Pharmacoepidemiology
(pages 633–659): Jesse A. Berlin
Chapter 39 Validity of Pharmacoepidemiology Drug and Diagnosis
Data (pages 661–705): Suzanne L. West, Brian L. Strom and
Charles Poole
Chapter 40 Special Methodological Issues in
Pharmacoepidemiology Studies of Vaccine Safety (pages 707–732):
Robert T. Chen
Chapter 41 Special Methodological Issues in
Pharmacoepidemiology Studies of Devices (pages 733–747):
Roselie A. Bright
Chapter 42 Special Considerations in Studies of Drug?induced
Birth Defects (pages 749–763): Allen A. Mitchell
Chapter 43 Bias and Confounding in Pharmacoepidemiology (pages
765–784): Jean?Paul Collet and Jean?Francois Boivin
Chapter 44 Novel Approaches to Pharmacoepidemiology Study
Design and Statistical Analysis (pages 785–805): Samy
Suissa
Chapter 45 The Future of Pharmacoepidemiology (pages 807–816):
Brian L. Strom
